Coirier V, Lescoat A, Fournet M, Cazalets C, Coiffier G, Jouneau S, Chabanne C, Jégo P
Service de médecine interne, hôpital Sud, CHU de Rennes, BP 90347, 16, boulevard de Bulgarie, 35203 Rennes cedex 2, France.
Service de médecine interne, hôpital Sud, CHU de Rennes, BP 90347, 16, boulevard de Bulgarie, 35203 Rennes cedex 2, France; UMR Inserm U1085, institut de recherche sur la santé, l'environnement et le travail (IRSET), université de Rennes 1, 35203 Rennes, France.
Rev Med Interne. 2017 Aug;38(8):502-507. doi: 10.1016/j.revmed.2017.04.005. Epub 2017 May 22.
Pulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis and detecting PAH efficiently remains challenging. The DETECT study has offered in 2013 a composite screening tool for PAH. The objective of our study was to compare the indication of right heart catheterisation (RHC) as suggested by the DETECT algorithm with the decisions of a multidisciplinary team.
This prospective monocentric non-interventional study consecutively included systemic sclerosis patients when data required to apply DETECT algorithm were available. We evaluate the number of RHC as requested by this algorithm and confronted it with the indications of RHC suggested by a multidisciplinary group blinded for the result of DETECT algorithm.
In total, 117 systemic sclerosis patients were included. When DETECT algorithm was applied to all patients, RHC was suggested by this algorithm for 70 patients, whereas only 15 indications were required by the multidisciplinary group; among those patients only 7 had PAH. When DETECT algorithm was applied only to the 42 patients with DLCO<60% and disease duration of more than 3 years, RHC was suggested for 31 patients whereas only 13 were indicated by the multidisciplinary group; among those patients only 7 had PAH.
The DETECT algorithm is able to efficiently detect all PAH patients finally diagnosed by our multidisciplinary team. However, it increases by 3 the number of RHC that should be performed.
肺动脉高压(PAH)是系统性硬化症的一种严重并发症,有效检测PAH仍然具有挑战性。DETECT研究在2013年提供了一种用于PAH的综合筛查工具。我们研究的目的是比较DETECT算法所建议的右心导管检查(RHC)指征与多学科团队的决策。
这项前瞻性单中心非干预性研究在可获得应用DETECT算法所需数据时连续纳入系统性硬化症患者。我们评估了该算法所要求的RHC数量,并将其与对DETECT算法结果不知情的多学科小组所建议的RHC指征进行对比。
总共纳入了117例系统性硬化症患者。当将DETECT算法应用于所有患者时,该算法建议对70例患者进行RHC,而多学科小组仅要求15例进行RHC;在这些患者中只有7例患有PAH。当仅将DETECT算法应用于42例DLCO<60%且病程超过3年的患者时,建议对31例患者进行RHC,而多学科小组仅指出13例;在这些患者中只有7例患有PAH。
DETECT算法能够有效检测出最终由我们的多学科团队确诊的所有PAH患者。然而,它将应进行的RHC数量增加了3倍。